Approval · Notice of Compliance 17028 · 2015
CIMZIA: Notice of Compliance 17028
Issued June 12, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17028
- Date
- June 12, 2015
- Company
- Ucb Canada IncOakville, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New drug product manufacturing site for the dreug product
- Therapeutic class
- Biological response modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CIMZIA | Not yet assigned | — |
Medicinal ingredients
- CERTOLIZUMAB PEGOL 200 MG per ML